Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,305 USD | +1,54% | -2,93% | -22,92% |
Métier
Nombre d'employés: 94
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Programmable Epigenomic mRNA Medicines
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +49,25% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +49,25% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 01/06/19 |
Joshua Reed
DFI | Director of Finance/CFO | 51 | 23/05/22 |
Chief Tech/Sci/R&D Officer | - | 01/01/21 | |
Samir Padalkar
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/21 |
Ling Zeng
ADM | Chief Administrative Officer | 55 | 30/03/22 |
Thomas McCauley
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/07/19 |
Yan Moore
CTO | Chief Tech/Sci/R&D Officer | 58 | 10/01/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 01/05/21 |
John Mendlein
BRD | Director/Board Member | 64 | 01/01/20 |
Christian Schade
CHM | Chairman | 63 | 10/07/23 |
Mary Szela
BRD | Director/Board Member | 61 | 01/06/19 |
Richard Young
BRD | Director/Board Member | 70 | 01/08/17 |
Michelle Werner
BRD | Director/Board Member | - | 28/08/23 |
Elliott Levy
BRD | Director/Board Member | 64 | 01/03/21 |
Rainer Boehm
BRD | Director/Board Member | 63 | 01/09/22 |
Mahesh Karande
CEO | Chief Executive Officer | 51 | 01/06/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 55 154 985 | 50 558 255 ( 91,67 %) | 0 | 91,67 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-22,92% | 125 M | |
+2,53% | 42,75 Md | |
+47,70% | 41,61 Md | |
+12,05% | 41,34 Md | |
-8,83% | 26,59 Md | |
+7,06% | 25,49 Md | |
-22,86% | 18,12 Md | |
+30,41% | 12,24 Md | |
-2,05% | 11,76 Md | |
+9,15% | 11 Md |
- Bourse
- Actions
- Action OMGA
- Société Omega Therapeutics, Inc.